Home/Filings/4/A/0000914190-18-000090
4/A//SEC Filing

Pinto Moshe 4/A

Accession 0000914190-18-000090

CIK 0001196298other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:09 PM ET

Size

12.5 KB

Accession

0000914190-18-000090

Insider Transaction Report

Form 4/AAmended
Period: 2017-12-20
Pinto Moshe
Director
Transactions
  • Award

    Common Stock

    2017-12-20+73,864156,445 total
  • Award

    Stock Option (Right to Buy)

    2017-12-20+40,28440,284 total
    Exercise: $0.50Exp: 2027-12-20Common Stock (40,284 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.45Exp: 2025-08-14Common Stock (59,155 underlying)
    59,155
  • Stock Option (Right to Buy)

    Exercise: $0.40Exp: 2026-08-24Common Stock (33,880 underlying)
    33,880
Footnotes (4)
  • [F1]On December 20, 2017, the Company granted 73,864 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Pinto in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]The option vests as to 19,719 shares on 8/14/16 and as to 19,718 shares on each of 8/14/17 and 8/14/18.
  • [F3]The option vests as to 11,294 shares on 8/24/16 and as to 11,293 shares on each of 8/24/17 and 8/24/18.
  • [F4]On December 20, 2017, the Company granted an option to purchase 40,284 shares of common stock of the Company (the "Option") in respect of the service by Mr. Pinto as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. The Option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001651255

Filing Metadata

Form type
4/A
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:09 PM ET
Size
12.5 KB